INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹352 Cr | ₹406 Cr | ₹351 Cr | ₹297 Cr | ₹234 Cr |
What is the latest Sundry Debtors ratio of INDOCO REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹352 Cr |
| Mar2024 | ₹406 Cr |
| Mar2023 | ₹351 Cr |
| Mar2022 | ₹297 Cr |
| Mar2021 | ₹234 Cr |
How is Sundry Debtors of INDOCO REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹352 Cr | -13.24 | |
| Mar2024 | ₹406 Cr | 15.75 | |
| Mar2023 | ₹351 Cr | 18.06 | |
| Mar2022 | ₹297 Cr | 27.12 | |
| Mar2021 | ₹234 Cr | - | |
Compare Sundry Debtors of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,053.7 Cr | 0.4% | -10.7% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 0.4% |
-10.7% |
-25.5% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses